A Clinical research on â??KALLADAIPPUâ?? (KIDNEY STONE) With the Siddha drug â??AAVARAI VITHAADHI CHOORANAMâ??

A Clinical Study on â??KALLADAIPPUâ?? (UROLITHIASIS) With the evaluation of Siddha drug â??AAVARAI VITHAADHI CHOORANAMâ??

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2015/01/005469

Enrollment

Registered

2015-01-27

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- MALE AND FEMALE WITH RENAL ANGLE PAIN AND BURNING MICTURITION

Interventions

Intervention1: AAVARAI VITHAADHI CHOORANAM: DOSE 1 GRAM BD WITH HONEY DURATION 48 DAYS Control Intervention1: NIL: NIL

Eligibility

Inclusion criteria

Inclusion criteria: Age 15 to 60 years Willing to participate in trial and signing in consent proforma History of Urolithiasis (with USG-Whole Abdomen reports) Flank Pain Burning Micturition Nausea Vomiting Oliguria Dysuria Haematuria Fever

Exclusion criteria

Exclusion criteria: Hydronephrosis Calculi associated with elevated serum creatinine level Calculi in pregnancy

Design outcomes

Primary

Measure	Time frame
Primary outcome is mainly assessed by reduction in clinical symptoms and by comparing the following parameters before and after treatment. 1. Renal function test 2. USG â?? Whole Abdomen Timepoint: 48 days	—

Secondary

Measure	Time frame
Secondary outcome is assessed by comparing the safety parameters before and after treatmentTimepoint: 48 DAYS	—

Countries

India

Contacts

Public ContactDR P PARTHIBAN

GOVERNMENT SIDDHA MEDICAL COLLEGE

drkkanakavalli@gmail.com9444122865

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026